Medical device firm delists from stock market

The move comes due to poor liquidity in Mainstay’s shares, very few of which were actively traded

7th June, 2020
Medical device firm delists from stock market
Mainstay has said that the delisting from Dublin, and also the Paris stock market, was down to the poor liquidity in its shares

Mainstay, the medical device maker, has had its plans to delist from the Dublin stock market approved by the High Court, ending its short life as a public company.

Mainstay has said that the delisting from Dublin, and also the Paris stock market, was down to the poor liquidity in its shares with very few actively traded, which depressed its value. The delisting means investors will receive one new share for every one they currently...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month, €19.99 Monthly thereafter

Get basic

*New subscribers only

You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

2 Yearly

€315

€248

Unlimited Access for 2 Years

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

Lucinda Creighton: Forget the exercise bike, the ‘perk’ your staff need is quality of life

Fibre-based drinks firm to make 20 more products as demand rises

SMEs Killian Woods 2 days ago

How to manage: Boomerang candidates cost more, but have unique value